Abstract
mRNA expression in DLBCL patients who are CD20 dim with an eye towards more thoughtful design of R/R trials, possibly incorporating BCMA Bite therapy
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have